{"DataElement":{"publicId":"3387872","version":"1","preferredName":"Head and Neck Tumor Histologic Classification Clinical Trial Eligibility Criteria Category","preferredDefinition":"information related to the histologic classification or category of a head and neck tumor which is necessary to allow an individual to participate in a specific clinical trial.","longName":"2195124v1.0:3387843v1.0","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"2195124","version":"1","preferredName":"Head and Neck Tumor Histologic Classification","preferredDefinition":"information related to the histologic classification or category of a head and neck tumor.","longName":"HDNCK_TUM_HIST_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2228482","version":"1","preferredName":"Head and Neck Neoplasm","preferredDefinition":"For oncology, area of the body generally construed to comprise base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12418:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck","conceptCode":"C12418","definition":"For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6EF4E2B-72AC-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-12","modifiedBy":"ONEDATA","dateModified":"2005-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207691","version":"1","preferredName":"Histologic Classification","preferredDefinition":"Of or relating to histology.:Classification; the grouping of things into classes or categories.","longName":"C25526:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2C90-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED053B9F-B4D1-0BAE-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3387843","version":"1","preferredName":"Head and Neck Tumor Histologic Classification Clinical Trial Eligibility Criteria Category","preferredDefinition":"the structural pattern of cancer cells used to define a diagnosis for head and neck cancer which is necessary to allow an individual to participate in a specific clinical trial.","longName":"3387843v1.0","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"High-grade acinic cell carcinoma or high-grade (>30% solid component) adenoid cystic carcinoma","valueDescription":"Salivary Gland Acinic Cell Carcinoma Adenoid Cystic Carcinoma High Grade","ValueMeaning":{"publicId":"3387847","version":"1","preferredName":"Salivary Gland Acinic Cell Carcinoma Adenoid Cystic Carcinoma High Grade","longName":"3387847","preferredDefinition":"A carcinoma of the salivary gland characterized by serous acinar cell differentiation.  The vast majority of cases occur in the parotid gland.  It usually presents as a slowly enlarging mass.  A minority of patients experience pain.  It may recur or metastasize.  Multiple recurrences and metastasis to cervical lymph nodes are usually associated with a poor prognosis.: A malignant tumor arising from the epithelial cells. Microscopically, the neoplastic epithelial cells form cylindrical spatial configurations (cribriform or classic type of adenoid cystic carcinoma), cordlike structures (tubular type of adenoid cystic carcinoma), or solid structures (basaloid variant of adenoid cystic carcinoma). Adenoid cystic carcinomas mostly occur in the salivary glands. Other primary sites of involvement include the lacrimal gland, the larynx, and the lungs. Adenoid cystic carcinomas spread along nerve sheaths, resulting in severe pain, and they tend to recur. Lymph node metastases are unusual; hematogenous tumor spread is characteristic.: Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Salivary Gland Acinic Cell Carcinoma","conceptCode":"C8013","definition":"A carcinoma of the salivary gland characterized by serous acinar cell differentiation.  The vast majority of cases occur in the parotid gland.  It usually presents as a slowly enlarging mass.  A minority of patients experience pain.  It may recur or metastasize.  Multiple recurrences and metastasis to cervical lymph nodes are usually associated with a poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Adenoid Cystic Carcinoma","conceptCode":"C2970","definition":"A malignant tumor arising from the epithelial cells.  Microscopically, the neoplastic epithelial cells form cylindrical spatial configurations (cribriform or classic type of adenoid cystic carcinoma), cordlike structures (tubular type of adenoid cystic carcinoma), or solid structures (basaloid variant of adenoid cystic carcinoma).  Adenoid cystic carcinomas mostly occur in the salivary glands.  Other primary sites of involvement include the lacrimal gland, the larynx, and the lungs.  Adenoid cystic carcinomas spread along nerve sheaths, resulting in severe pain, and they tend to recur.  Lymph node metastases are unusual; hematogenous tumor spread is characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"High Grade","conceptCode":"C14158","definition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9F57D82-7DAA-4B58-E040-BB89AD437DD8","latestVersionIndicator":"Yes","beginDate":"2012-02-27","endDate":null,"createdBy":"PATELV","dateCreated":"2012-02-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9F57D82-7DC3-4B58-E040-BB89AD437DD8","beginDate":"2012-02-27","endDate":null,"createdBy":"PATELV","dateCreated":"2012-02-27","modifiedBy":"ONEDATA","dateModified":"2012-02-27","deletedIndicator":"No"},{"value":"Intermediate-grade adenocarcinoma or intermediate-grade mucoepidermoid carcinoma","valueDescription":"Adenocarcinoma Mucoepidermoid Carcinoma Intermediate Grade","ValueMeaning":{"publicId":"3387844","version":"1","preferredName":"Adenocarcinoma Mucoepidermoid Carcinoma Intermediate Grade","longName":"3387844","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.: A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.: A term referring to the degree of differentiation of a malignant neoplasm and indicating that it is moderately differentiated.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mucoepidermoid Carcinoma","conceptCode":"C3772","definition":"A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Intermediate Grade","conceptCode":"C28083","definition":"A term referring to the degree of differentiation of a malignant neoplasm and indicating that it is moderately differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9F57D82-7D5A-4B58-E040-BB89AD437DD8","latestVersionIndicator":"Yes","beginDate":"2012-02-27","endDate":null,"createdBy":"PATELV","dateCreated":"2012-02-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9F57D82-7D73-4B58-E040-BB89AD437DD8","beginDate":"2012-02-27","endDate":null,"createdBy":"PATELV","dateCreated":"2012-02-27","modifiedBy":"ONEDATA","dateModified":"2012-02-27","deletedIndicator":"No"},{"value":"High-grade adenocarcinoma or high-grade mucoepidermoid carcinoma or salivary duct carcinoma","valueDescription":"Adenocarcinoma Mucoepidermoid Carcinoma Salivary Duct Carcinoma High Grade","ValueMeaning":{"publicId":"3387845","version":"1","preferredName":"Adenocarcinoma Mucoepidermoid Carcinoma Salivary Duct Carcinoma High Grade","longName":"3387845","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.: A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.: An aggressive, high grade adenocarcinoma that arises from the salivary glands. It usually affects elderly males and presents as a rapidly enlarging mass. It metastasizes to regional lymph nodes and distant anatomic sites.: Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Mucoepidermoid Carcinoma","conceptCode":"C3772","definition":"A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Salivary Duct Carcinoma","conceptCode":"C5904","definition":"An aggressive, high grade adenocarcinoma that arises from the salivary glands. It usually affects elderly males and presents as a rapidly enlarging mass. It metastasizes to regional lymph nodes and distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"High Grade","conceptCode":"C14158","definition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9F57D82-7D82-4B58-E040-BB89AD437DD8","latestVersionIndicator":"Yes","beginDate":"2012-02-27","endDate":null,"createdBy":"PATELV","dateCreated":"2012-02-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B9F57D82-7D9B-4B58-E040-BB89AD437DD8","beginDate":"2012-02-27","endDate":null,"createdBy":"PATELV","dateCreated":"2012-02-27","modifiedBy":"ONEDATA","dateModified":"2012-02-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3387842","version":"1","preferredName":"Clinical Trial Eligibility Criteria Category","preferredDefinition":"Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.:Category; used informally to mean a class of things.","longName":"C16112:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9F57D82-7D31-4B58-E040-BB89AD437DD8","latestVersionIndicator":"Yes","beginDate":"2012-02-27","endDate":null,"createdBy":"PATELV","dateCreated":"2012-02-27","modifiedBy":"ONEDATA","dateModified":"2012-02-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9F57D82-7D42-4B58-E040-BB89AD437DD8","latestVersionIndicator":"Yes","beginDate":"2012-02-27","endDate":null,"createdBy":"PATELV","dateCreated":"2012-02-27","modifiedBy":"SBR","dateModified":"2014-01-24","changeDescription":" Changed from CTEP to NRG for by script Fri Jan 24 11:30:54 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171053","version":"1","longName":"RTOG-1008","context":"NRG"}]},{"publicId":"6147165","version":"1","longName":"Wake Forest Baptist Medical Center","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6147167","version":"1","longName":"WFB","context":"NCIP"}]}],"AlternateNames":[{"name":"2195124v1.0:3387843v1.0","type":"USED_BY","context":"NRG"},{"name":"NCIP","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"CTEP"},{"name":"WF1805CD","type":"Alternate Question Text","description":"Head and neck tumor histology of lymphoma, adenocarcinoma or melanoma.","url":null,"context":"NCIP"}],"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9F7013B-6238-E4F5-E040-BB89AD4340FD","latestVersionIndicator":"Yes","beginDate":"2012-02-27","endDate":null,"createdBy":"PATELV","dateCreated":"2012-02-27","modifiedBy":"RODGERSC","dateModified":"2019-11-13","changeDescription":" Changed from CTEP to NRG for by script Fri Jan 24 11:30:54 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}